Skip to content
Drug recall · FDA · Published March 28, 2019

Aurobindo Pharma USA Inc. recalls Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E

Aurobindo Pharma USA Inc recalls Lidocaine HCl Injection vials from India with a hair found inside. This could cause injury during medical use. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-1248-2019DrugAurobind: Aurobindo Pharma USA Inc ›
Take action

Contact the company & request your remedy

Recalling firmAurobindo Pharma USA Inc.279 Princeton Hightstown Rd, N/A · East Windsor, NJ 08520-1401
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Aurobindo Pharma USA Inc is recalling Lidocaine HCl Injection vials that were found to contain a hair. This could cause injury during medical use, so affected users should stop using the product and contact the manufacturer. Read more at govinfonow.com/recall/39066-aurobindo-lidocaine-injection-recall-hair-in-vial-causes-potential-injury.

Source Summary by GovInfoNow · govinfonow.com/recall/39066-aurobindo-lidocaine-injection-recall-hair-in-vial-causes-potential-injury · Updated October 5, 2026 · FDA enforcement record: FDA #D-1248-2019

Cite this page

“Aurobindo Lidocaine Injection Recall: Hair in vial causes potential injury.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39066-aurobindo-lidocaine-injection-recall-hair-in-vial-causes-potential-injury. Based on FDA recall #D-1248-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1248-2019%22&limit=1).

Why it’s dangerous

The vial contains a hair that could be introduced into the bloodstream during injection, potentially causing injury or infection. This is a rare finding but can happen with any medication product.

Who’s affected

Patients using this prescription medication in the U.S. are affected. Those with medical procedures requiring lidocaine injections are at higher risk.

How to tell if you have this one

Check for the vial label with NDC 55150-162-05, Lot # CLC180117, and expiration date June 2021. The product was sold in India by AuroMedics Pharna LLC.

  • Brand
    Aurobind: Aurobindo Pharma USA Inc
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the NDC code 55150-162-05 and lot number CLC180117 on the vial.

  2. Contact Manufacturer

    Reach out to Aurobindo Pharma USA Inc for further instructions on handling the recalled product.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product was found to contain a hair, which could cause injury during medical use. Do not use this vial.

How can I tell if I have the recalled product?

Check for the NDC code 55150-162-05 and lot number CLC180117 on the vial label.

What should I do if I have the recalled product?

Contact Aurobindo Pharma USA Inc for instructions on how to handle the recalled product.

Take action

Contact Aurobind: Aurobindo Pharma USA Inc

We’ve drafted a message you can send Aurobind: Aurobindo Pharma USA Inc to request your refund or repair — edit it as you like.

Subject: Recall D-1248-2019 — Aurobind: Aurobindo Pharma USA Inc Aurobind: Aurobindo Pharma USA Inc

Hello,

I own a Aurobind: Aurobindo Pharma USA Inc that is covered by recall D-1248-2019 from Aurobind: Aurobindo Pharma USA Inc.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1248-2019 (March 28, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1248-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA